New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2022, Therapeutics and COVID-19: living guideline, 16 September 2022.
View latest version (2022)Bibliographic information
GuidelineTherapeutics and COVID-19: living guideline, 17 December 2020.
Year of Publication2020
Issuing InstitutionWorld Health Organization
Recommendation
Retired
Originally developed
Therapeutics and COVID-19. The World Health Organization (WHO) suggests against administering remdesivir in addition to usual care
Recommended against
Conditional
Certainty of evidence
Very low
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Therapeutics and COVID-19: living guideline, 31 March 2021.
Year2021
InstitutionWorld Health Organization
Guideline
Therapeutics and COVID-19: living guideline, 6 July 2021.
Year2021
InstitutionWorld Health Organization
Guideline
Therapeutics and COVID-19: living guideline, 24 September 2021.
Year2021
InstitutionWorld Health Organization
Guideline
Therapeutics and COVID-19. Living guideline. 7 December 2021
Year2021
InstitutionWorld Health Organization
Guideline
Therapeutics and COVID-19: living guideline, 14 January 2022.
Year2022
InstitutionWorld Health Organization